Ken Fenster
About Ken Fenster
Ken Fenster serves as the Sr. Director of Commercial Operations at OPKO Health, Inc., where he oversees commercial supply chain and patient services. He holds an M.B.A. from Babson College and has significant experience in the pharmaceutical industry, including leading the launch of Rayaldee®, the first FDA-approved treatment for secondary hyperparathyroidism in chronic kidney disease patients.
Work at OPKO Health
Ken Fenster serves as the Senior Director of Commercial Operations at OPKO Health, Inc. since 2016. In this role, he is responsible for overseeing commercial supply chain operations and patient services for the company. His responsibilities include managing third-party logistics, trade, specialty pharmacy, patient hub services, and physician sampling specifically for OPKO Renal. His leadership has been instrumental in the company's operational efficiency and service delivery.
Education and Expertise
Ken Fenster holds a Master of Business Administration (M.B.A.) from Babson F.W. Olin Graduate School of Business, where he studied Marketing. He also earned a Bachelor of Arts (B.A.) from the University of Wisconsin-Madison. His educational background provides a solid foundation for his expertise in commercial operations within the pharmaceutical industry.
Background in Pharmaceutical Marketing
Prior to his current role, Ken Fenster worked as the Executive Director of Marketing at Anda, Inc. from 2008 to 2015. His tenure at Anda, Inc. spanned seven years and was based in Weston, FL. He also held the position of Product Manager at Apotex Inc. from 2006 to 2008, further enhancing his experience in the pharmaceutical sector.
Key Achievements in Product Launch
Ken Fenster led the launch of Rayaldee®, which is recognized as the first and only FDA-approved treatment for secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease who have vitamin D insufficiency. This achievement highlights his capability in managing significant product launches within the pharmaceutical industry.